# EDGAR Filing Document

**Accession Number:** 0001513988
**File Stem:** 0001610717-25-000373
**Filing Date:** 2025-11
**Character Count:** 9406
**Document Hash:** f39c3fd4d81f6200fe1aab2cdfd3bf7f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001610717-25-000373.hdr.sgml**: 20251110

**ACCESSION NUMBER**: 0001610717-25-000373

**CONFORMED SUBMISSION TYPE**: 4/A

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251001

**FILED AS OF DATE**: 20251110

**DATE AS OF CHANGE**: 20251110

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** AMIN TARANG
- **CENTRAL INDEX KEY:** 0001513988

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37873
- **FILM NUMBER:** 251466452

**MAIL ADDRESS:**
- **STREET 1:** C/O SCHIFF NUTRITION INTERNATIONAL, INC.
- **STREET 2:** 2002 SOUTH 5070 WEST
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84104
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** e.l.f. Beauty, Inc.
- **CENTRAL INDEX KEY:** 0001600033
- **STANDARD INDUSTRIAL CLASSIFICATION:** PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 464464131
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**BUSINESS ADDRESS:**
- **STREET 1:** 601 12TH STREET
- **STREET 2:** SUITE 1400
- **CITY:** OAKLAND
- **STATE:** CA
- **BUSINESS PHONE:** (510) 778-7787

**MAIL ADDRESS:**
- **STREET 1:** 601 12TH STREET
- **STREET 2:** SUITE 1400
- **CITY:** OAKLAND
- **STATE:** CA

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** J.A. Cosmetics Holdings, Inc.
- **DATE OF NAME CHANGE:** 20140212

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4/A

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[x] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>AMIN TARANG<br><sub>(Last) (First) (Middle)</sub><br>C/O E.L.F. BEAUTY, INC.<br>570 10TH STREET<br><sub>(Street)</sub><br>OAKLAND, CA 94607<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-10-01 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Executive Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>e.l.f. Beauty, Inc. [ ELF ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock, $0.01 par value | 2025-10-01 |  | M<sup>(1)</sup> |  | 194537 | A | $17 | 276355<sup>(2)</sup> | D |  |
| Common Stock, $0.01 par value | 2025-10-01 |  | S<sup>(1)</sup> |  | 6817 | D | 130.3629<sup>(3)</sup> | 269538<sup>(2)</sup> | D |  |
| Common Stock, $0.01 par value | 2025-10-01 |  | S<sup>(1)</sup> |  | 33038 | D | 131.8583<sup>(4)</sup> | 236500<sup>(2)</sup> | D |  |
| Common Stock, $0.01 par value | 2025-10-01 |  | S<sup>(1)</sup> |  | 64030 | D | 132.4099<sup>(5)</sup> | 172470<sup>(2)</sup> | D |  |
| Common Stock, $0.01 par value | 2025-10-01 |  | S<sup>(1)</sup> |  | 12430 | D | 133.4391<sup>(6)</sup> | 160040<sup>(2)</sup> | D |  |
| Common Stock, $0.01 par value |  |  |  |  |  |  |  | 228037 | I | By Family Trust |
| Common Stock, $0.01 par value |  |  |  |  |  |  |  | 228037 | I | By Family Trust |
| Common Stock, $0.01 par value |  |  |  |  |  |  |  | 468532 | I | By Amin Family General Partnership |
| Common Stock, $0.01 par value |  |  |  |  |  |  |  | 40295 | I | By 2025 Family Trust I |
| Common Stock, $0.01 par value |  |  |  |  |  |  |  | 40295 | I | By 2025 Family Trust II |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Option (Right to Buy) | $17 | 2025-10-01 |  | M<sup>(1)</sup> |  |  | 194537 | <sup>(7)</sup> | 2026-09-21 | Common Stock | 194537 | $0 | 0 | D |  |

---

### Footnotes:

(1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025 and in connection with an exercise of stock options set to expire in September 2026. The sales reported herein were made solely to cover tax liabilities in connection with the exercise of stock options. The Reporting Person otherwise retained the remaining shares from the exercise.

(2) Includes 81,818 restricted stock units.

(3) The transaction was executed in multiple trades in prices ranging from $130.05 to $130.76, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

(4) The transaction was executed in multiple trades in prices ranging from $131.07 to $132.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

(5) The transaction was executed in multiple trades in prices ranging from $132.07 to $133.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

(6) The transaction was executed in multiple trades in prices ranging from $133.07 to $134.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

(7) The stock option is fully vested and exercisable.

**Remarks:**
On October 3, 2025, the reporting person filed a Form 4 which inadvertently reported the wrong number of exercised shares.

**Signature:** /s/ Scott K. Milsten, Attorney-in-Fact for Tarang Amin  
**Date:** 2025-11-10

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**